Cargando…
Antibodies to combat viral infections: development strategies and progress
Monoclonal antibodies (mAbs) are appealing as potential therapeutics and prophylactics for viral infections owing to characteristics such as their high specificity and their ability to enhance immune responses. Furthermore, antibody engineering can be used to strengthen effector function and prolong...
Autores principales: | Pantaleo, Giuseppe, Correia, Bruno, Fenwick, Craig, Joo, Victor S., Perez, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207876/ https://www.ncbi.nlm.nih.gov/pubmed/35725925 http://dx.doi.org/10.1038/s41573-022-00495-3 |
Ejemplares similares
-
Antibodies to Combat Fungal Infections: Development Strategies and Progress
por: Rabaan, Ali A., et al.
Publicado: (2023) -
Single-Domain Antibodies and Their Formatting to Combat Viral Infections
por: De Vlieger, Dorien, et al.
Publicado: (2018) -
Immunomodulatory nanosystems: An emerging strategy to combat viral infections
por: Khatun, Sajmina, et al.
Publicado: (2023) -
T‐cell exhaustion in HIV infection
por: Fenwick, Craig, et al.
Publicado: (2019) -
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
por: Tompa, Dharma Rao, et al.
Publicado: (2021)